Matthew C. Riddle i wsp. A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks. Diabetes Care 2018 Jun; 41(6): 1121-1124 (dostępny pełen tekst)
A set of guidance statements recently published by the American College of Physicians (ACP) advocates relaxation of goals for control of glycated hemoglobin (A1C) by people with type 2 diabetes (T2D) … We believe the ACP recommendations fail to consider several important bodies of scientific evidence, and if they are widely adopted in clinical practice, the recent progress in management of diabetes may be threatened.
Diabetes Care, czerwiec 2018